Table 2.
Meta analyzed results of COVID-19 common clinical symptoms.
| Proportions | 95% Confidence interval | Heterogeneity test, I2 | Heterogeneity test, P Value | Number of studies | |
|---|---|---|---|---|---|
| Fever | 76.70% | 64.86%–85.44% | 99.7% | 0 | 21 |
| Cough | 67.76% | 60.06%– 74.61% | 99.2% | <0.0001 | 21 |
| Olfactory | 40.80% | 20.31%– 65.08% | 99.4% | 0 | 14 |
| Gustatory | 34.52% | 18.83%–54.50% | 98.9% | < 0.0001 | 13 |
| Dyspnea | 37.49% | 26.20%– 50.34% | 99.6 | 0 | 19 |
| Fatigue | 29.93% | 14.22%– 52.39% | 99.7% | <0.0001 | 11 |
| Sputum production | 17.85% | 9.25%– 31.65% | 99.1% | <0.0001 | 10 |
| Sore throat | 16.17% | 10.05%– 24.98% | 96.9% | <0.0001 | 9 |
| Headache | 15.49% | 7.83%– 28.33% | 98.7% | <0.0001 | 12 |